NUCLEOS(T)IDE ANALOG THERAPY OF CHRONIC HEPATITIS B AND LIVER CANCER RISK REDUCTION: BETTER NUCLEOTIDES THAN NUCLEOSIDES?

Posted on October 14, 2019 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.